Table 6. Histo- and cytopathology follow-up results.
Cytology | Histology | ||||||
classification | n (%) | Normal | CIN 1 | CIN 2 | CIN 3+ | No histology | |
1. Study group * | |||||||
a. Persisting type specific hr-HPV (n = 91) | |||||||
No cytology | 1 (1.1) | 1 | |||||
Normal | 55 (60.4) | 55 | |||||
ASCUS | 16 (17.6) | 4 | 2 | 1 | 9 | ||
LSIL | 10 (11.0) | 1 | 6 | 1 | 6 | ||
HSIL | 9 (9.9) | 3 | 5 | 1 | |||
b. Cleared type-specific hr-HPV (n = 75) | |||||||
Normal | 52 (69.3) | 52 | |||||
ASCUS | 15 (20.0) | 3 | 1 | 11 | |||
LSIL | 5 (6.7) | 1 | 1 | 1 | 1 | 1 | |
HSIL | 3 (4.0) | 1 | 1 | 1 | 0 | ||
2. Control group # | |||||||
(n = 246) | |||||||
Normal | 227 (92.3) | 227 | |||||
ASCUS | 14 (5.7) | 1 | 13 | ||||
LSIL | 2 (0.8) | 1 | 1 | ||||
HSIL | 3 (1.2) | 2 | 1 |
*Study group: study month 12 hr-HPV positive women. Mean interval between study month 12 and cytology = 13 months.
Control group: study month 12 hr-HPV negative women. Mean interval between study month 12 and cytology = 12 months.